Organisation paid for research Program year 2025 Source: CMS Open Payments

Vida Clinical Studies

Neither a doctor nor a teaching hospital

Research payments

$1,821,176

257 payments

Through program year 2025, Vida Clinical Studies is reported as receiving $1,821,176 in research payments, across 257 payments.

By program year

6 rows

Year	Kind	Amount	Payments
2025	Research	$1,040,245	138
2024	Research	$66,950	111
2023	Research	$693,019	4
2021	Research	$5,250	1
2020	Research	$490	1
2019	Research	$15,223	2

Breakdown

Who paid Research payments · program years 2019–2025

Ortho-Clinical Diagnostics, Inc. $1,000,091 10 payments
Cue Health Inc. $656,392 1 payment
Indivior Inc. $72,629 231 payments
Moderna TX, Inc. $61,652 10 payments
Boehringer Ingelheim Pharmaceuticals, Inc. $20,963 4 payments
OraSure Technologies Inc. $9,450 1 payment

Studies the money was for Research payments · program years 2019–2025

Savanna RVP4X Assay $978,439 9 payments
RSV $656,392 1 payment
A Phase IV Longitudinal Study of SUBLOCADE (SUBUTEX Prolonged Release) Clinical Outcomes in Adults With Opioid Use Disorder (Opioid Dependence) $72,629 231 payments
A multi-phase, adaptive, randomized, observer-blind, placebo- and active-control study to evaluate the safety, reactogenicity, and immunogenicity of mRNA-based influenza and SARS-CoV-2 multi-component vaccines in healthy adults $61,652 10 payments
Savanna RVP4X Enrichment Panel Preparation $21,652 1 payment
COPD pragmatic randomised clinical trial $20,963 4 payments
Sherlock Biosciences, Inc. The PROMISE Study $9,450 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.